Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
Novo Nordisk’s stock suffered its biggest one-day slide on record after its latest obesity drug trial disappointed investors hoping for…
Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says
Advertisement Shares of pharmaceutical companies that produce popular weight loss drugs have tumbled since president-elect Donald Trump named Robert F.…
